Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
3 Nov 2026HutchmedHMPL-306 in Participants With Postoperative Residual or Recurrent Grade 2 Glioma Harboring IDH1 or IDH2 MutationsPhase 3Not Yet Recruiting3 Nov 2026InnovStone Therapeutics LimitedA Study Evaluating the Efficacy and Safety of SYH2072 Tablets In Hypertensive PatientsPhase 2Not Yet Recruiting3 Nov 2026Jiangsu Hansoh Pharmaceutical Co., Ltd.ChinaPhase 3 Study of HS-10380 for Acute Schizophrenia in Chinese AdultsPhase 3Not Yet Recruiting3 Nov 2026Jiangsu HengRui Medicine Co., Ltd.ChinaA Study Comparing SHR-3167 With Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal InsulinPhase 3Not Yet Recruiting3 Nov 2026Jiangsu Simcere Pharmaceutical Co., Ltd.ChinaStudy of SIM0518 in Participants With ALK-Positive or ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerPhase 1Not Yet Recruiting3 Nov 2026Lambda Surgical, IncUnited StatesObservational Study of the LambdaGuide System for Measurement of Observable Genitourinary Anatomy During Cystoscopic Procedures in MenRecruiting3 Nov 2026Leukos Biotech S.L.SpainEvaluation of LB-208 (HTR1B Antagonist) in Adult Patients With Relapsed or Refractory Solid Tumours and LymphomaPhase 1Recruiting3 Nov 2026Mabwell (Shanghai) Bioscience Co., Ltd.ChinaPhase 1 Study of 6MW5311 in Adults With Relapsed or Refractory Blood CancersPhase 1Recruiting3 Nov 2026Metagen Therapeutics, Inc.United States, JapanSafety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT Study)Phase 1, Phase 2Recruiting3 Nov 2026MIBIO PTE. LTD.GeorgiarhTPO for Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Procedures.Phase 3Recruiting3 Nov 2026NeoChordEarly Feasibility Study of NeoChord Transcatheter Mitral Repair SystemNot applicableNot Yet Recruiting3 Nov 2026PharmaResearch Co.,LtdMalaysia, Singapore, ThailandClinical Research on Deep-Plane Rejuran S Injection for Improvement in the Apperance of Periorbital Hollowing Using a Cannula TechniqueNot Yet Recruiting3 Nov 2026PharmaResearch Co.,LtdMalaysia, Singapore, ThailandClinical Evaluation of Dual-Plane Technique PN-Based Treatment for Horizontal Neck Lines Using DNA Fragment Opmizing Technology Polynucleotide (DOT PN)Not Yet Recruiting3 Nov 2026Profil Institut für Stoffwechselforschung GmbHUnited StatesClinical Research Trial to Study Insulin Sensitivity Using Automated Glucose Clamp TechnologyNot Yet Recruiting3 Nov 2026Pulse Biosciences, Inc.United StatesTreating PHPT With the nPulse™ Vybrance™ PE SystemNot applicableNot Yet Recruiting3 Nov 2026Radicle ScienceUnited StatesImpact of Lepteridine™ Mānuka Honey in Adults With Gastrointestinal DiscomfortNot applicableNot Yet Recruiting3 Nov 2026Royan Stem Cell Technology CompanyIranARTEMIS: Umbilical Cord-Derived Mesenchymal Stromal Cells (UC-MSCs) After Mechanical Thrombectomy for Acute Ischemic StrokePhase 1Not Yet Recruiting3 Nov 2026Sinfatin S.LSpainRimonabant for Improving Walking Ability in Patients With Chronic StrokePhase 2Not Yet Recruiting3 Nov 2026Sonova AGUnited StatesPerformance of a Remote Microphone Compared to Hearing Aids AloneNot applicableActive Not Recruiting3 Nov 2026Tavo BiotherapeuticsUnited StatesA Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With Glaucoma or High Eye Pressure.Phase 2Recruiting3 Nov 2026Teva Branded Pharmaceutical Products R&D LLCReal-World Impact of TV-44749 in Adults With SchizophreniaNot Yet Recruiting3 Nov 2026Xintian PharmaceuticalChinaClinical Study on the Efficacy and Safety of Heyan® Kuntai Capsules in Alleviating Perimenopausal Symptoms Induced by GnRH-aPhase 4Completed3 Nov 2026Yuhan CorporationSouth KoreaBioequivalence Study Between YHP2508A and YHR2601 in Healthy SubjectsPhase 1Recruiting3 Nov 2026Yuhan CorporationSouth KoreaBioequivalence Study Between YHP2508B and YHR2602 in Healthy SubjectsPhase 1Recruiting2 Nov 2026AmgenUnited StatesComparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)Phase 1Recruiting2 Nov 2026AmgenComparing the Extent to Which Apremilast is Made Available in the Body After Administration as an Extended-release or Immediate-release FormulationPhase 1Not Yet Recruiting2 Nov 2026AstraZenecaUnited KingdomA Trial to Assess the Relative Bioavailability of Different Subcutaneous Formulations of AZD9550 and AZD6234Phase 1Not Yet Recruiting2 Nov 2026AstraZenecaA Study to Evaluate Surovatamig Combined With R-CHOP in Participants of 18 to < 80 Years of Age With Previously Untreated Large B-cell Lymphoma With IPI Score 2 to 5Phase 3Not Yet Recruiting2 Nov 2026Beta Bionics, Inc.Safety and Efficacy of the Fully Closed Loop iLet Bionic Pancreas in Adults With Type 1 and Type 2 DiabetesNot applicableNot Yet Recruiting2 Nov 2026ChM sp. z o.o.PolandStudy Evaluating the Safety and Efficacy of the TMChM Prosthesis in the Treatment of People With Chronic Flexor Tendon Fingers InjuriesNot applicableNot Yet Recruiting2 Nov 2026Crescent Biopharma, Inc.United StatesCR-002 in Adult Participants With Locally Advanced or Metastatic Solid TumorsPhase 1, Phase 2Recruiting2 Nov 2026Cristcot LLCA Three-Arm, Randomized, Placebo-Controlled, Double-Blind Phase 2 Study to Evaluate the Safety and Efficacy of Two Dosage Regimens of a Novel Hydrocortisone Acetate Suppository Formulation Administered With a Proprietary Suppository Applicator in Subjects With Hemorrhoidal DiseasePhase 2Not Yet Recruiting2 Nov 2026Enanta Pharmaceuticals, IncUnited StatesA Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe DiseasePhase 2, Phase 3Recruiting2 Nov 2026Encora, Inc.United StatesThe Encora X1™ in a Real World Observational StudyRecruiting2 Nov 2026Galderma R&DChinaA Study to Evaluate the Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour DeficienciesNot applicableNot Yet Recruiting2 Nov 2026Gilead SciencesStudy of BIC/LEN FDC Versus Stable Baseline Regimens in Virologically Suppressed People With HIVPhase 4Not Yet Recruiting2 Nov 2026GlaxoSmithKlineB-Ensure: Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study ParticipantsPhase 4Not Yet Recruiting2 Nov 2026Guangzhou Patronus Biotech Co., Ltd.ChinaA Study to Evaluate Efficacy, Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and OlderPhase 3Not Yet Recruiting2 Nov 2026HALEONSingaporeA Study Evaluating the Impact of a Painkiller Product on Quality-of-Life and Daily FunctioningNot Yet Recruiting2 Nov 2026Hamad Medical CorporationQatarA Novel Treatment for Chronic Low Back Pain Using Multi Angular Isometric Lumbar Exercise: Randomized Clinical Trial.Not applicableRecruiting2 Nov 2026HerAccess ApSDenmarkIntegrated Care Pathway for Hormonally Mediated Vestibulodynia: a Feasibility and Acceptability PilotNot applicableNot Yet Recruiting2 Nov 2026JemincareA Study to Investigate the Pharmacokinetics of JMKX003142 in Healthy Participants and Participants With Hepatic ImpairmentPhase 1Not Yet Recruiting2 Nov 2026Jiangsu Jingze Biopharmaceutical Co., Ltd.ChinaA Study Evaluating the Efficacy and Safety of Recombinant Human Truncated Plasmin Injection (JZB32) in Patients With Vitreomacular TractionPhase 2Recruiting2 Nov 2026Kanvas BiosciencesUnited States, CanadaA Phase 1 Trial of KAN-001 With Pembrolizumab, With or Without Chemotherapy, in Participants With PD-L1-Positive Non-Small Cell Lung CancerPhase 1Not Yet Recruiting2 Nov 2026Keymed Biosciences Co.LtdChinaStudy of CM336+CM313 Combination Therapy in Patients With Relapsed or Refractory Multiple MyelomaPhase 3Not Yet Recruiting2 Nov 2026Medicovestor, IncUnited StatesA Study of MC001 in Patients With Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) and Other Folate Receptor Alpha (FRα)-Expressing Solid TumorsPhase 1Not Yet Recruiting2 Nov 2026Merck Sharp & Dohme LLCA Clinical Trial of Gocatamig (MK-6070) With Durvalumab in Participants With Small Cell Lung Cancer (MK-6070-004)Phase 3Not Yet Recruiting2 Nov 2026Merck Sharp & Dohme LLCMK-2870-U01 Substudy 1: A Clinical Trial of Sacituzumab Tirumotecan to Treat Prostate Cancer (MK-2870-01A)Phase 1, Phase 2Not Yet Recruiting2 Nov 2026Nanjing Chia-tai Tianqing PharmaceuticalChinaA Phase 1 Clinical Trial of NTQ6179 Tablets in Healthy VolunteersPhase 1Recruiting2 Nov 2026Novartis PharmaceuticalsUnited StatesA Study to Assess the Safety, Tolerability and Pharmacokinetics of XEP527 in Patients With Stable SchizophreniaPhase 1Recruiting// How AOS uses this